Ally Bridge Group

Ally Bridge Group

Ally Bridge Group

Suggest edits
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 15

Portfolio

Portfolio Tracker

Add info
Add round
09 Nov 2021
Arbor Biotechnologies
Arbor Biotechnologies
$215,000,000
Venture capital (Series B)
ARCH Venture Partners, Vertex, Tao Capital Partners, +17

CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies

MedCity News
02 Nov 2021
Shoreline Biosciences
Shoreline Biosciences
$140,000,000
Venture capital
Cormorant Asset Management, Boxer Capital, Ally Bridge Group, +12

Shoreline Biosciences secures $140M for off-the-shelf NK cell therapies for cancer

MedCity News
24 Sep 2021
Elligo Health Research
Elligo Health Research
$135,000,000
Venture capital (Series E)
Hatteras Venture Partners, Morgan Stanley Expansion Capital, Ally Bridge Group, +3

Cerner joins $135M funding round for Elligo Health Research 

MedCity News
04 Aug 2021
Sonoma Biotherapeutics
Sonoma Biotherapeutics
$265,000,000
Venture capital (Series B)
ARCH Venture Partners, Frazier Healthcare Partners, Casdin Capital, +5

Sonoma Biotherapeutics raises $265M to advance therapies for autoimmune, inflammatory diseases

GeekWire
21 Aug 2020
Chinook Therapeutics
Chinook Therapeutics
$106,000,000
Post-IPO equity
Versant Ventures, Rock Springs Capital, OrbiMed, +9

Chinook Therapeutics Raises $106M in Funding

FinSMEs
20 May 2020
Rapid Micro Biosystems
Rapid Micro Biosystems
$120,000,000
Venture capital
Endeavour Vision, Xeraya Capital, Longitude Capital, +3

Rapid Micro Biosystems Raises $120M in Funding

FinSMEs
+1
05 May 2020
Pulmonx Corporation
Pulmonx Corporation
$66,000,000
Venture capital (Series H)
Adage Capital Management, Rock Springs Capital, HealthQuest Capital, +2

Pulmonx Raises $66M in Financing

FinSMEs
13 May 2019
Pulmonx Corporation
Pulmonx Corporation
$65,000,000
Undisclosed
Ally Bridge Group

HK’s Ally Bridge Group leads $65m financing for US-based Pulmonx

DealStreetAsia
23 Apr 2019
Duoning Biotech
Duoning Biotech
CNY ¥100,000,000
Venture capital (Series A)
Ally Bridge Group, WuXi Biologics
22 May 2018
GRAIL
GRAIL
$300,000,000
Venture capital (Series C)
Ally Bridge Group, Lifetech Scientific

Healthcare Company Grail Raises $300M in Financing

FinSMEs
+6
26 Apr 2018
Innovent Biologics
Innovent Biologics
$150,000,000
Venture capital (Series E)
Legend Capital, Rock Springs Capital, Cormorant Asset Management, +6

CGPM leads $150 mln Series E for Innovent Biologics

PE HUB
+2
22 Nov 2016
Shockwave Medical, Inc.
Shockwave Medical, Inc.
$45,000,000
Venture capital (Series C)
RA Capital Management, Venrock, Sofinnova Partners, +4

Shockwave Medical raises $45m Series C for Lithoplasty device

MassDevice
+1
11 Apr 2016
Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc.
$150,000,000
Post-IPO equity
Ally Bridge Group

Ally Bridge leads $150m round for US cancer treatment firm

AVCJ
05 Apr 2016
LinkDoc Technology
LinkDoc Technology
Venture capital (Series B)
NEA, China Broadband Capital, Ally Bridge Group, +1

Data firm LinkDoc raises Series B led by China Broadband Capital

DealStreetAsia
15 Dec 2015
AltheaDx
AltheaDx
$30,000,000
Venture capital (Series C)
WuXi Healthcare Ventures, WuXi PharmaTech, Ally Bridge Group, +1

AltheaDx Raises $30M to Help Doctors Personalize Treatment

Xconomy
+1